Aparna Bhardwaj

Jan 4, 2024 | biorxiv.org | Kumar Ankur |Aparna Bhardwaj |Richa Joshi |Taniya Bhardwaj

AbstractIn the last decades, many efforts have been put forward in search of inhibitors/drugs specific to ZIKV-infected patients. These inhibitors include approved drugs, natural products, nucleosides, small molecules, and many others to inhibit Zika virus replication in cell and mouse models. In this regard, natural product curcumin has been widely explored in various disease conditions and found to have inhibition potential against ZIKV replication as well.